{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:29:49Z","timestamp":1766158189802},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,5]]},"DOI":"10.4103\/0366-6999.237401","type":"journal-article","created":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T09:12:43Z","timestamp":1532423563000},"page":"1767-1775","source":"Crossref","is-referenced-by-count":9,"title":["Three-year Follow-up on the Safety and Effectiveness of Rituximab Plus Chemotherapy as First-Line Treatment of Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in Real-World Clinical Settings in China"],"prefix":"10.1097","volume":"131","author":[{"given":"Jian-Qiu","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Ping","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Ping","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Zhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Huan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuo-Xing","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie-Wen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Nong","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Ping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Min","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Zhi","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Shi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Min","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong-Jian","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Feng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210129","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"R2-2-20210129","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"R3-2-20210129","first-page":"193","article-title":"Clinicopathologic study of 369 B-cell non-Hodgkin lymphoma cases, with reference to the 2001 World Health Organization classification of lymphoid neoplasms (in Chinese)","volume":"34","author":"Zhang","year":"2005","journal-title":"Chin J Pathol"},{"key":"R5-2-20210129","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"R6-2-20210129","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1470-2045(06)70664-7","article-title":"CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: A randomised controlled trial by the MabThera International Trial (MInT) Group","volume":"7","author":"Pfreundschuh","year":"2006","journal-title":"Lancet Oncol"},{"key":"R7-2-20210129","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S1470-2045(11)70235-2","article-title":"CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group","volume":"12","author":"Pfreundschuh","year":"2011","journal-title":"Lancet Oncol"},{"key":"R8-2-20210129","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1470-2045(08)70002-0","article-title":"Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: A randomised controlled trial (RICOVER-60)","volume":"9","author":"Pfreundschuh","year":"2008","journal-title":"Lancet Oncol"},{"key":"R9-2-20210129","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","article-title":"Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: A study by the Groupe D'etudes des Lymphomes de L'adulte","volume":"116","author":"Coiffier","year":"2010","journal-title":"Blood"},{"key":"R10-2-20210129","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2004-08-3175","article-title":"CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma","volume":"105","author":"Marcus","year":"2005","journal-title":"Blood"},{"key":"R11-2-20210129","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1200\/JOP.2012.000597","article-title":"Hepatitis B screening before chemotherapy: A survey of practitioners' knowledge, beliefs, and screening practices","volume":"8","author":"Lee","year":"2012","journal-title":"J Oncol Pract"},{"key":"R12-2-20210129","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1016\/j.ejim.2013.07.008","article-title":"Awareness of hepatitis B virus reactivation among physicians authorized to prescribe chemotherapy","volume":"24","author":"Turker","year":"2013","journal-title":"Eur J Intern Med"},{"key":"R13-2-20210129","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1186\/s12885-016-2523-7","article-title":"Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: A prospective, multicentre, non-interventional study","volume":"16","author":"Wu","year":"2016","journal-title":"BMC Cancer"},{"key":"R15-2-20210129","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"R16-2-20210129","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1470-2045(11)70069-9","article-title":"Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: A multicentre, single-arm, phase 2 trial","volume":"12","author":"Peyrade","year":"2011","journal-title":"Lancet Oncol"},{"key":"R17-2-20210129","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s12185-009-0475-2","article-title":"Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan: A retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group","volume":"91","author":"Seki","year":"2010","journal-title":"Int J Hematol"},{"key":"R18-2-20210129","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.amjms.2017.02.002","article-title":"The enhanced international prognostic index for diffuse large B-cell lymphoma","volume":"353","author":"Yang","year":"2017","journal-title":"Am J Med Sci"},{"key":"R19-2-20210129","first-page":"756","article-title":"Efficacy of additional two cycles of rituximab administration for patients with diffuse large B-cell lymphoma in first remission (in Chinese)","volume":"37","author":"Zhong","year":"2016","journal-title":"Chin J Hematol"},{"key":"R20-2-20210129","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1517\/14740338.2014.918948","article-title":"A drug safety evaluation of rituximab and risk of hepatitis B","volume":"13","author":"Riedell","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"R21-2-20210129","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.clinre.2014.07.010","article-title":"Prophylactic lamivudine to improve the outcome of HBsAg-positive lymphoma patients during chemotherapy: A systematic review and meta-analysis","volume":"39","author":"Li","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R22-2-20210129","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s12072-017-9817-y","article-title":"Risk of hepatitis B reactivation in HBsAg-negative\/HBcAb-positive patients with undetectable serum HBV DNA after treatment with rituximab for lymphoma: A meta-analysis","volume":"11","author":"Tang","year":"2017","journal-title":"Hepatol Int"},{"key":"R24-2-20210129","doi-asserted-by":"crossref","first-page":"257","DOI":"10.6004\/jnccn.2013.0037","article-title":"Non-Hodgkin's lymphomas, version 1.2013","volume":"11","author":"Zelenetz","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"key":"R25-2-20210129","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1056\/NEJM200306263482619","article-title":"Interstitial pneumonitis related to rituximab therapy","volume":"348","author":"Burton","year":"2003","journal-title":"N Engl J Med"},{"key":"R26-2-20210129","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1586\/14737167.7.4.319","article-title":"The cost-effectiveness of rituximab in non-Hodgkin's lymphoma","volume":"7","author":"Knight","year":"2007","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"R27-2-20210129","doi-asserted-by":"crossref","first-page":"A888","DOI":"10.1016\/j.jval.2016.08.271","article-title":"Cost-effectiveness of rituximab in the treatment of diffuse large b-cell non-Hodgkin's lymphoma patients (Dlbcl) in China","volume":"19","author":"Xu","year":"2016","journal-title":"Value Health"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/0366-6999.237401","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T19:48:28Z","timestamp":1623959308000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00029330-201808050-00002"}},"subtitle":["A Prospective, Multicenter, Noninterventional Study"],"short-title":[],"issued":{"date-parts":[[2018,8,5]]},"references-count":24,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/0366-6999.237401","relation":{},"ISSN":["0366-6999"],"issn-type":[{"value":"0366-6999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8,5]]}}}